These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3162444)

  • 41. Immunohistochemical reactivity of monoclonal antibodies to human milk fat globule with breast carcinoma and with other normal and neoplastic tissues.
    Helle M; Krohn K
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):43-51. PubMed ID: 3515847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cloning and sequencing of a complementary DNA encoding a Mr 70,000 human breast epithelial mucin-associated antigen.
    Larocca D; Peterson JA; Walkup G; Urrea R; Ceriani RL
    Cancer Res; 1990 Sep; 50(18):5925-30. PubMed ID: 2393862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy.
    Halila H; Stenman UH; Seppälä M
    Cancer; 1986 Apr; 57(7):1327-9. PubMed ID: 3456253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CA 15-3 serum levels in ovarian cancer.
    Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
    Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MCA, a monoclonal-antibody-defined breast-tumor-associated antigen and its relation to CA 15.3.
    Bieglmayer C; Szepesi T; Neunteufel W; Nowotny C
    Tumour Biol; 1989; 10(5):232-42. PubMed ID: 2814232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G; Zippel HH; Würz H
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.
    Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A
    Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating CA 15-3 antigen levels in non-mammary malignancies.
    Colomer R; Ruibal A; Genollà J; Salvador L
    Br J Cancer; 1989 Feb; 59(2):283-6. PubMed ID: 2930693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CA 125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovary.
    Einhorn N; Knapp RC; Bast RC; Zurawski VR
    Acta Oncol; 1989; 28(5):655-7. PubMed ID: 2590540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breast.
    Góźdź SS; Kowalska MM; Słuszniak JT; Słuszniak A; Korejba W; Bukowski J; Banasińska E; al-Jazzaf H; Szymendera JJ
    Tumour Biol; 1989; 10(2):103-8. PubMed ID: 2734547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of epithelial ovarian-cancer-associated antigens involved in immune complexes by monoclonal antibodies.
    Kawata M; Sekiya S
    Tumour Biol; 1998; 19(1):1-11. PubMed ID: 9422077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Tumor markers in gynecologic diseases].
    Geyer H; Kleine W
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):168-72. PubMed ID: 3472991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
    Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
    Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
    Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas.
    Altaras MM; Goldberg GL; Levin W; Bloch B; Darge L; Smith JA
    Gynecol Oncol; 1988 May; 30(1):26-34. PubMed ID: 2452770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies for the development of monoclonal antibodies for in vivo imaging: their use in the imaging of ovarian carcinoma.
    Burchell J; Taylor-Papadimitriou J; Griffiths AB
    Cancer Detect Prev Suppl; 1987; 1():241-7. PubMed ID: 3480054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humanization of an anti-mucin antibody for breast and ovarian cancer therapy.
    Baker TS; Bose CC; Caskey-Finney HM; King DJ; Lawson AD; Lyons A; Mountain A; Owens RJ; Rolfe MR; Sehdev M
    Adv Exp Med Biol; 1994; 353():61-82. PubMed ID: 7985543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.